Ethambutol is a commonly used first-line anti-tuberculosis agent, and its most important potential side-effect is ethambutol-induced optic neuropathy (EON). Understanding of the incidence,clinical characteristics, risk factors, prognosis and mechanism of EON is of practical significance in the diagnosis and treatment of this disorder. This article reviews the present status of these aspects.